The Pertussis resurgence: putting together the pieces of the puzzle

Rotem Lapidot1, Christopher J Gill2,3

  • 1Department of Pediatric Infectious Diseases, Boston Medical Center, Boston, MA USA.

Insights

Rising pertussis cases are linked to acellular pertussis (aP) vaccines. Differences in immune responses compared to whole-cell pertussis (wP) vaccines, particularly the lack of mucosal immunity, may explain the resurgence.

Area of Science:

  • Immunology
  • Epidemiology
  • Vaccinology

Background:

  • Pertussis (whooping cough) incidence is increasing globally.
  • This rise occurs despite widespread use of acellular pertussis (aP) vaccines.
  • Existing explanations like waning immunity and improved diagnostics are insufficient.

Purpose of the Study:

  • To investigate the reasons behind the resurgence of pertussis.
  • To explore the role of differing immune responses between aP and whole-cell pertussis (wP) vaccines.
  • To determine if aP vaccines' lack of mucosal immunity contributes to pertussis incidence.

Main Methods:

  • Comparative analysis of immune responses induced by aP versus wP vaccines.
  • Review of epidemiological data on pertussis incidence trends.
  • Assessment of vaccine-induced immunity, including mucosal immunity.

Main Results:

  • Immune responses to aP vaccines differ fundamentally from those induced by wP vaccines.
  • aP vaccines do not appear to induce significant mucosal immunity.
  • These differences may be a critical factor in the observed pertussis resurgence.

Conclusions:

  • The shift from wP to aP vaccines may be a key driver of the current pertussis epidemic.
  • Lack of mucosal immunity following aP vaccination warrants further investigation.
  • Understanding these vaccine-induced immune differences is crucial for controlling pertussis.

Related Concept Videos

Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
622
Vaccinations01:51

Vaccinations

Overview
52.2K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
560
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
954
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
663
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.7K